# Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery

> **NCT04685421** · PHASE1 · TERMINATED · sponsor: **Nicklaus Children's Hospital f/k/a Miami Children's Hospital** · enrollment: 15 (actual)

## Conditions studied

- Cardiac Conditions

## Interventions

- **DRUG:** Bupivacaine liposome

## Key facts

- **NCT ID:** NCT04685421
- **Lead sponsor:** Nicklaus Children's Hospital f/k/a Miami Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-15
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** PI, Christopher Tirotta, no longer at NCH as of 5-26-23.
- **Last updated:** 2023-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04685421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04685421, "Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04685421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*